PubMed Health⌕ Search

Biomedical subjects

J Slanina

Publications and source records attributed to J Slanina.

At least 55 records · Page 3Linked to original sources
PubMed1979

[Lymphocyte response to phytohemagglutinin-stimulation after extended radiation therapy in Hodgkin's disease (author's transl)].

Phytohemagglutinin-stimulated DNA-synthesis of lymphocytes was measured in 35 patients with Hodgkin's disease in continuous remission 1 to 8 years after intensive high-energy radiotherapy. In comparison to a normal control group we found there was no significant difference between the values of patients in complete remission and healthy subjects. We conclude that the extremely suppressed lymphocytic reactivity as measured by DNA-synthesis during irradiation may again reach normal values one or two years after radiotherapy.

Adolescent↗
PubMed1979

[Prognostic factors in epipharyngeal tumors: a retrospective analysis of 151 patients treated at Freiburg (Breisgau) between 1948 and 1977 (author's transl)].

From 1948 through 1977, 151 patients with an epipharyngeal tumor underwent radiation therapy at our department. A retrospective analysis was made reviewing treatment results and prognostic features. The 5-year survival rate of the total group amounted to 39%, the 10-year survival to 27%. Tumor stage and histology were confirmed as the preponderant factors in prognostication. Stage T1--2 cases had a 5-year survival rate of 57%, which decreased to 46% if unilateral lymph node metastases had occurred, and down to 17% in case of bilateral metastasition to the lymph nodes. Of stage T3--4 patients, 45% survived during 5 years. Lymphoepithelial carcinoma, with a 5-year survival rate of 54%, had a better prognosis than squamous cell carcinoma (47%), transitional cell carcinoma (30%) and reticulum cell sarcoma (30%). A review of the results other authors have obtained since 1956 with combinations of surgical and irradiation methods gives evidence that the efficiency of techniques confined to local or regional treatment has reached its limits. At present, further improvement may be achieved mainly by means of systematically applied adjuvant chemotherapy complementary to the general thérapeutic concept.

Carcinoma, Squamous Cell↗
PubMed1978

[Present state of the wide-field megavoltage radiotherapy of Hodgkin's disease. Fundamentals, performance, side effects (author's transl)].

Therapeutic results of Hodgkin's disease could be significantly improved by the introduction of megavoltage radiotherapy equipment and more profound knowledge about this disease. By this way, five year survival rates of 70% can be achieved for all stages and up to 100% for the early stages. The wide field technique enables the coverage of all lymph nodes with protection of non involved organs. Simultaneously, these improved technical conditions make optimal radiation planning necessary which demands numerous technical auxiliaries. Radiation type and radiation energy are important preconditions for the therapy; production and usage of shilding blocks are necessary for individual performance. The principle for optimal radiation dose distribution are measurements and calculations on the phantom which are now included in computer programs. Nevertheless, radiation of large volumes represent a high stress for the patient. Despite the improvement of the therapeutic results there are except the acute radiation side effects, also irreversible alterations. These can be analysed only after long time observations and has to be balanced with the therapeutic results. The knowledge of these side effects is very important for the radiologist. Beside that, the risk of induction of a second tumor has to be considered. The present possibilities of absolute control of this disease enables the overtreatment of lesions in the early stages. Therefore it has to be postulated to regard the present therapy concepts with attention and to consider the possible side effects.

Acute Disease↗
PubMed1978

[Investigation of the NAD metabolism in the spleen of patients with Hodgkin's disease (author's transl)].

A correlation between the NAD metabolism and DNA synthesis, that means cell proliferation, was observed in the course of experimental studies using mouse tissues. The present studies revealed a similar correlation also in splenic tissues of patients with Hodgkin's disease. The enzymatic activities of NAD-pyrophosphorylase and NAD-glycohydrolase were measured in detail in isolated cell nuclei. NAD-pyrophosphorylase activity was particularly increased in patients with Hodgkin's disease. A decrease of enzymatic activity was seen following radiation therapy, and especially 24 hours after local irradiation of the spleen with 200 rd(60Co). These studies are in accordance with former results obtained in mice.

Adolescent↗
PubMed1977

[Primary and secondary exploratory laparotomy and splenectomy in Hodgkin's disease (author's transl)].

Exploratory laparotomy with splenectomy was performed on 275 patients with hisologically confirmed Hodgkin's disease. In 188 patients the laparotomy was a primary one to determine more precisely the state of the disease. A secondary laparotomy was performed in 87 patients 1-12 years after diagnosis and radiotherapy. In 17.5% of patients the state had to be revised after laparotomy with splenectomy. In 38 the disease had further progressed, while in ten it had slighty regressed. In four cases clinical stage I proved to be stage III. Even prognostically more favourable forms may have progressed at first diagnosis. There was no correlation between B-symptoms and histological type, but there was between B-symptoms and spread of the disease. Calculated spleen weight provided no clue as to spleen involvement. There was no clear relationship between spleen involvement and histological subclassification. Risk-effect analysis indicate that laparotomy with splenectomy was useful because it makes optimal treatment possible.

Adult↗